Combined PMCA and cell assays are being optimised for use as an effective, or even superior, alternative to quantitative prion bioassays in laboratory rodents
Get full access to this article
View all access options for this article.
References
1.
PrusinerS.B. (1998). Prions. Proceedings of the National Academy of Sciences of the USA95, 13, 363–13, 383.
2.
ColbyD.W. & PrusinerS.B. (2011). Prions. Cold Spring Harbor Perspectives in Biology3, a006833.
3.
BrownP. & CervenakovaL. (2005). A prion lexicon (out of control). Lancet365, 122.
4.
ComeJ.H., FraserP.E. & LansburyP. T. (1993). A kinetic model for amyloid formation in the prion diseases: Importance of seeding. Proceedings of the National Academy of Sciences of the USA90, 5959–5963.
5.
SotoC. (2011). Prion hypothesis: The end of the controversy?Trends in Biochemical Sciences36, 151–158.
6.
PrusinerS.B. (1987). Bioassays of prions. In Prions — Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease (ed. PrusinerS.B. & McKinleyM.P.), pp. 65–81. San Diego, New York, Toronto: Academic Press.
7.
RussellW.M.S. & BurchR.L. (1959). The Principles of Humane Experimental Technique, 238pp. London, UK: Methuen.
8.
KlöhnP.C., StoltzeL., FlechsigE., EnariM. & WeissmannC. (2003). A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proceedings of the National Academy of Sciences of the USA100, 11, 666–11, 671.
9.
MahalS.P., DemczykC.A., SmithE.W., KlöhnP.C. & WeissmannC. (2008). Assaying prions in cell culture: The standard scrapie cell assay (SSCA) and the scrapie cell assay in end point format (SCEPA). Methods in Molecular Biology459, 49–68.
10.
EdgeworthJ.A., JacksonG.S., ClarkeA.R., WeissmannC. & CollingeJ. (2009). Highly sensitive, quantitative cell-based assay for prions absorbed to solid surfaces. Proceedings of the National Academy of Sciences of the USA106, 3479–3483.
11.
Arellano-AnayaZ.E., SavistchenkoJ., MatheyJ., HuorA., LacrouxC., AndreolettiO. & ViletteD. (2011). A simple, versatile and sensitive cell-based assay for prions from various species. PLoS One6, e20563.
12.
BianJ., NapierD., KhaychuckV., AngersR., GrahamC. & TellingG. (2010). Cell-based quantification of chronic wasting disease prions. Journal of Virology84, 8322–8326.
13.
SaborioG.P., PermanneB. & SotoC. (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature411, 810–813.
14.
ChenB., MoralesR., BarriaM.A. & SotoC. (2010). Estimating prion concentration in fluids and tissues by quantitative PMCA. Nature Methods7, 519–520.
15.
WilhamJ.M., OrruC.D., BessenR.A., AtarashiR., SanoK., RaceB., Meade-WhiteK.D., TaubnerL.M., TimmesA. & CaugheyB. (2010). Rapid endpoint quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathogens6, e1001217.
16.
PritzkowS., WagenführK., DausM.L., BoernerS., LemmerK., ThomzigA., MielkeM. & BeekesM. (2011). Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection. PLoS One6, e20384.
17.
MakaravaN., SavtchenkoR., AlexeevaI., RohwerR.G. & BaskakovI.V. (2012). Fast and ultrasensitive method for quantitating prion infectivity titre. Nature Communications3, 741.
18.
AguzziA. & CalellaA.M. (2009). Prions: Protein aggregation and infectious disease. Physiological Reviews89, 1105–1152.
19.
LasmezasC.I., DeslysJ.P., RobainO., JaeglyA., BeringueV., PeyrinJ.M., FournierJ.G., HauwJ.J., RossierJ. & DormontD. (1997). Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science275, 402–405.
20.
RaceR., Meade-WhiteK., RainesA., RaymondG.J., CaugheyB. & ChesebroB. (2002). Subclinical scrapie infection in a resistant species: Persistence, replication, and adaptation of infectivity during four passages. Journal of Infectious Diseases186, Suppl. 2, S166–S170.
21.
BarronR.M., CampbellS.L., KingD., BellonA., ChapmanK.E., WilliamsonR.A. & MansonJ.C. (2007). High titres of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. Journal of Biological Chemistry282, 35, 878–35, 886.
22.
DobyK. & BarronR. (2013). Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and Proteinase K-resistant PrPSc levels in peripheral tissue from a murine transgenic model of TSE disease. Journal of Virology87, 5895–5903.
23.
BoernerS., WagenführK., DausM.L., ThomzigA. & BeekesM. (2013). Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays. Laboratory Animals47, 106–115.
